SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Aarti Pharmalabs informs about press release

29 Apr 2025 Evaluate
Pursuant to Regulation 30 of Listing Regulations, Aarti Pharmalabs has enclosed a Press Release titled ‘Aarti Pharmalabs Earns EcoVadis Gold Rating, Among Top 5% Globally for Sustainability’. The Press Release is also available on the website of the Company i.e. www.aartipharmalabs.com

The above information is a part of company’s filings submitted to BSE.

Aarti Pharmalabs Share Price

698.60 17.45 (2.56%)
01-Jul-2026 12:55 View Price Chart
Peers
Company Name CMP
Sun Pharma. Inds. 1872.85
Dr. Reddys Labs. 1343.10
Cipla 1453.55
Zydus Lifesciences 1110.00
Lupin 2402.40
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through: